BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31205490)

  • 1. Multimodal MRI characteristics of the glioblastoma infiltration beyond contrast enhancement.
    Yan JL; Li C; Boonzaier NR; Fountain DM; Larkin TJ; Matys T; van der Hoorn A; Price SJ
    Ther Adv Neurol Disord; 2019; 12():1756286419844664. PubMed ID: 31205490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal MRI can identify perfusion and metabolic changes in the invasive margin of glioblastomas.
    Price SJ; Young AM; Scotton WJ; Ching J; Mohsen LA; Boonzaier NR; Lupson VC; Griffiths JR; McLean MA; Larkin TJ
    J Magn Reson Imaging; 2016 Feb; 43(2):487-94. PubMed ID: 26140696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between DTI-derived metrics and MRS metabolites in tumour regions of glioblastoma: a pilot study.
    Flores-Alvarez E; Anselmo Rios Piedra E; Cruz-Priego GA; Durand-Muñoz C; Moreno-Jimenez S; Roldan-Valadez E
    Radiol Oncol; 2020 Sep; 54(4):394-408. PubMed ID: 32990651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing tumor invasiveness of glioblastoma using multiparametric magnetic resonance imaging.
    Li C; Wang S; Yan JL; Torheim T; Boonzaier NR; Sinha R; Matys T; Markowetz F; Price SJ
    J Neurosurg; 2019 Apr; 132(5):1465-1472. PubMed ID: 31026822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
    Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
    Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation analysis of expressions of PTEN and p53 with the value obtained by magnetic resonance spectroscopy and apparent diffusion coefficient in the tumor and the tumor-adjacent area in magnetic resonance imaging for glioblastoma.
    Li Y; Ji F; Jiang Y; Zhao T; Xu C
    J BUON; 2018; 23(2):391-397. PubMed ID: 29745082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance study on fractional anisotropy and neuronal metabolite ratios in peritumoral area of cerebral gliomas.
    Bieza A; Krumina G
    Medicina (Kaunas); 2012; 48(10):497-506. PubMed ID: 23324245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major Metabolite Levels of Preoperative Proton Magnetic Resonance Sectroscopy and Intraoperative Fluorescence Intensity in Glioblastoma.
    Tian HL; Zu YL; Wang CC; Lin T; Guo ZT; Jiang B; Yin X; Guo WQ; Wang ZG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):511-517. PubMed ID: 28877829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma.
    van Dijken BRJ; Jan van Laar P; Li C; Yan JL; Boonzaier NR; Price SJ; ; van der Hoorn A
    J Neurosurg; 2018 Oct; 131(3):717-723. PubMed ID: 30485234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
    Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
    Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis.
    Chuang MT; Liu YS; Tsai YS; Chen YC; Wang CK
    PLoS One; 2016; 11(1):e0141438. PubMed ID: 26741961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
    Zonari P; Baraldi P; Crisi G
    Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
    Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
    J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
    Zhou GF; Wang XY; Gong CG; Liu F; Wang RW
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.
    Askaner K; Rydelius A; Engelholm S; Knutsson L; Lätt J; Abul-Kasim K; Sundgren PC
    J Neuroradiol; 2019 Nov; 46(6):367-372. PubMed ID: 30389510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of choline levels and tumor perfusion in brain metastases assessed with proton MR spectroscopy and dynamic susceptibility contrast-enhanced perfusion weighted MRI.
    Huang BY; Kwock L; Castillo M; Smith JK
    Technol Cancer Res Treat; 2010 Aug; 9(4):327-37. PubMed ID: 20626199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.